Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
James Freeman MD, mPH, MS

James V. Freeman MD, mPH, MS

Professor of Medicine, Director Yale Cardiac Electrophysiology Laboratories, Director Yale Atrial Fibrillation Program, Yale School of Medicine and Yale New Haven Health, New Haven, Connecticut

James V. Freeman, MD, MPH, MS, is a Professor of Medicine in Cardiac Electrophysiology at Yale School of Medicine and Director of the Yale Cardiac Electrophysiology Laboratories and the Yale Atrial Fibrillation Program. He is an internationally recognized expert in the treatment of atrial fibrillation (AF) and has published extensively on the epidemiology of AF and on the safety, efficacy and cost-effectiveness of treatments for AF.

Disclosures

Dr. Freeman has received research funding from the National Institutes of Health/National Heart, Lung, and Blood Institute, and the American College of Cardiology National Cardiovascular Data Registry; has received consulting/advisory board fees from Medtronic, Boston Scientific, Biosense Webster, and PaceMate.